Aim for at least 8-10 glasses of water daily, but dont chug it all at once
The Anglo Peptides model is built specifically for the Canadian research market
Injectable tirzepatide shows: ~1521% average weight loss up to ~26% with lifestyle changes consistent long-term outcomes Oral GLP-1 drugs, like Rybelsus, typically show: lower weight loss at standard doses need for higher dosing to match injections stricter intake conditions If oral tirzepatide eventually becomes available, it will likely require higher doses, produce slower or less pronounced weight loss and come with stricter intake instructions
Higher Average Weight Loss: Clinical trials, including a direct head-to-head study (SURMOUNT-5), consistently show that Zepbound leads to greater average weight loss than Wegovy
The skin around the eyes is delicate and can be more prone to bruising
Our guides on how to wean off tirzepatide and how to maintain weight loss after stopping provide step-by-step protocols for transitioning off the medication while preserving your results